1. Home
  2. ASTE vs SYRE Comparison

ASTE vs SYRE Comparison

Compare ASTE & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASTE
  • SYRE
  • Stock Information
  • Founded
  • ASTE 1972
  • SYRE 2013
  • Country
  • ASTE United States
  • SYRE United States
  • Employees
  • ASTE N/A
  • SYRE N/A
  • Industry
  • ASTE Construction/Ag Equipment/Trucks
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASTE Industrials
  • SYRE Health Care
  • Exchange
  • ASTE Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • ASTE 1.1B
  • SYRE 1.1B
  • IPO Year
  • ASTE N/A
  • SYRE 2016
  • Fundamental
  • Price
  • ASTE $47.85
  • SYRE $14.84
  • Analyst Decision
  • ASTE Hold
  • SYRE Buy
  • Analyst Count
  • ASTE 1
  • SYRE 5
  • Target Price
  • ASTE $41.00
  • SYRE $55.00
  • AVG Volume (30 Days)
  • ASTE 176.1K
  • SYRE 438.2K
  • Earning Date
  • ASTE 11-05-2025
  • SYRE 11-06-2025
  • Dividend Yield
  • ASTE 1.09%
  • SYRE N/A
  • EPS Growth
  • ASTE N/A
  • SYRE N/A
  • EPS
  • ASTE 2.01
  • SYRE N/A
  • Revenue
  • ASTE $1,310,100,000.00
  • SYRE N/A
  • Revenue This Year
  • ASTE $8.19
  • SYRE N/A
  • Revenue Next Year
  • ASTE $9.14
  • SYRE N/A
  • P/E Ratio
  • ASTE $23.80
  • SYRE N/A
  • Revenue Growth
  • ASTE 1.17
  • SYRE N/A
  • 52 Week Low
  • ASTE $29.65
  • SYRE $10.91
  • 52 Week High
  • ASTE $48.04
  • SYRE $40.26
  • Technical
  • Relative Strength Index (RSI)
  • ASTE 61.01
  • SYRE 34.69
  • Support Level
  • ASTE $45.58
  • SYRE $15.80
  • Resistance Level
  • ASTE $47.71
  • SYRE $17.58
  • Average True Range (ATR)
  • ASTE 1.26
  • SYRE 0.75
  • MACD
  • ASTE -0.11
  • SYRE -0.20
  • Stochastic Oscillator
  • ASTE 90.27
  • SYRE 3.52

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: